Katarina Eeg‐Olofsson

4.0k total citations
85 papers, 2.5k citations indexed

About

Katarina Eeg‐Olofsson is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Katarina Eeg‐Olofsson has authored 85 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Cardiology and Cardiovascular Medicine and 18 papers in Surgery. Recurrent topics in Katarina Eeg‐Olofsson's work include Diabetes Management and Research (42 papers), Diabetes Treatment and Management (41 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Katarina Eeg‐Olofsson is often cited by papers focused on Diabetes Management and Research (42 papers), Diabetes Treatment and Management (41 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Katarina Eeg‐Olofsson collaborates with scholars based in Sweden, United Kingdom and Netherlands. Katarina Eeg‐Olofsson's co-authors include Björn Eliasson, Soffia Guðbjörnsdóttir, Jan Cederholm, Björn Zethelius, Peter M. Nilsson, Ann‐Marie Svensson, Araz Rawshani, B. Zethelius, Junmei Miao Jonasson and Stefan Franzén and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Katarina Eeg‐Olofsson

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarina Eeg‐Olofsson Sweden 29 1.8k 652 581 410 349 85 2.5k
Mervete Miftaraj Sweden 20 1.9k 1.1× 660 1.0× 869 1.5× 305 0.7× 420 1.2× 49 2.8k
Aidin Rawshani Sweden 15 1.8k 1.0× 630 1.0× 908 1.6× 368 0.9× 456 1.3× 39 3.0k
Ann–Marie Svensson Sweden 14 2.0k 1.1× 591 0.9× 1.0k 1.7× 375 0.9× 408 1.2× 21 3.0k
Aldina Pivodic Sweden 23 1.6k 0.9× 843 1.3× 840 1.4× 644 1.6× 292 0.8× 119 3.1k
Jan Cederholm Sweden 31 1.9k 1.1× 450 0.7× 738 1.3× 286 0.7× 516 1.5× 76 2.9k
Michelle Magee United States 19 1.9k 1.1× 374 0.6× 706 1.2× 430 1.0× 369 1.1× 57 2.8k
Eric S. H. Lau Hong Kong 26 1.2k 0.7× 323 0.5× 282 0.5× 337 0.8× 389 1.1× 109 2.2k
Emanuela Orsi Italy 33 1.7k 1.0× 471 0.7× 452 0.8× 209 0.5× 358 1.0× 94 3.1k
Sandro Gentile Italy 26 1.2k 0.7× 426 0.7× 305 0.5× 282 0.7× 322 0.9× 102 2.2k
Harold W. de Valk Netherlands 34 1.5k 0.8× 831 1.3× 355 0.6× 410 1.0× 327 0.9× 117 3.4k

Countries citing papers authored by Katarina Eeg‐Olofsson

Since Specialization
Citations

This map shows the geographic impact of Katarina Eeg‐Olofsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Eeg‐Olofsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Eeg‐Olofsson more than expected).

Fields of papers citing papers by Katarina Eeg‐Olofsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Eeg‐Olofsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Eeg‐Olofsson. The network helps show where Katarina Eeg‐Olofsson may publish in the future.

Co-authorship network of co-authors of Katarina Eeg‐Olofsson

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Eeg‐Olofsson. A scholar is included among the top collaborators of Katarina Eeg‐Olofsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Eeg‐Olofsson. Katarina Eeg‐Olofsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eliasson, Björn, Hertzel C. Gerstein, Katarina Eeg‐Olofsson, et al.. (2025). Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study. Diabetes Care. 48(11). 1888–1895.
3.
Mubanga, Mwenya, Tong Gong, Emma Caffrey Osvald, et al.. (2025). Association between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study. Thorax. 80(6). 385–391. 2 indexed citations
4.
Carlsen, Hanne Krage, et al.. (2025). Hospitalisation from seasonal influenza among persons with type 1 diabetes: a cohort study from the Swedish National Diabetes Register. BMJ Open. 15(2). e084165–e084165. 1 indexed citations
5.
Trullenque‐Eriksson, Anna, Cristiano Tomasi, Katarina Eeg‐Olofsson, et al.. (2024). Periodontitis in patients with diabetes and its association with diabetes-related complications. A register-based cohort study. BMJ Open. 14(7). e087557–e087557. 7 indexed citations
6.
Sattar, Naveed, Araz Rawshani, Björn Eliasson, et al.. (2022). Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes. Diabetes Care. 45(10). 2326–2335. 19 indexed citations
7.
Celis‐Morales, Carlos, Stefan Franzén, Katarina Eeg‐Olofsson, et al.. (2022). Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care. 45(3). 634–641. 24 indexed citations
9.
Albanese-O’Neill, Anastasia, Julia M. Grimsmann, Ann‐Marie Svensson, et al.. (2021). Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective. Diabetes Technology & Therapeutics. 24(1). 32–41. 18 indexed citations
10.
Nathanson, David, Ann‐Marie Svensson, Mervete Miftaraj, et al.. (2021). Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia. 64(7). 1595–1603. 36 indexed citations
11.
Rawshani, Aidin, Aidin Rawshani, Araz Rawshani, et al.. (2021). Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study. The Lancet Regional Health - Europe. 4. 100105–100105. 85 indexed citations
13.
15.
Ekström, Nils, Mervete Miftaraj, Ann‐Marie Svensson, et al.. (2013). Durability of oral hypoglycaemic agents in drug naive patients with type 2 diabetes : observational study from the Swedish National Diabetes Register (NDR). Diabetologia. 56. 1 indexed citations
16.
Cederholm, Jan, Björn Eliasson, Björn Zethelius, Katarina Eeg‐Olofsson, & Soffia Guðbjörnsdóttir. (2013). [Risk factors for cardiovascular disease. Results from the Swedish national diabetes register compared with international studies].. PubMed. 110(17-18). 882–5. 2 indexed citations
17.
Ekström, Nils, Linus Schiöler, Ann‐Marie Svensson, et al.. (2012). Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2(4). e001076–e001076. 174 indexed citations
18.
Zethelius, Björn, et al.. (2010). Risk prediction of cardiovascular disease in type 2 diabetes : a new risk equation from the Swedish NDR. Diabetologia. 53. 1 indexed citations
19.
Cederholm, Jan, Peter M. Nilsson, Björn Eliasson, et al.. (2009). [Connections between risk factors and complications in diabetes. A report after 13 years with the National Diabetes Registry (NDR)].. PubMed. 106(42). 2684–9. 3 indexed citations
20.
Nilsson, Peter M., Jan Cederholm, Björn Eliasson, et al.. (2008). Successful long-term blood pressure control and lower incidence of cardiovascular disease: A report from the Swedish National Diabetes Register (NDR). Journal of Hypertension. 26. 202–202. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026